Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Winter cherry root (Withania somnifera), commonly known as ashwagandha, contains bioactive withanolides—including withaferin A, withanoside IV, and withanolide D—that modulate the hypothalamic-pituitary-adrenal (HPA) axis to reduce serum cortisol and enhance GABAergic neurotransmission, conferring adaptogenic, anxiolytic, and neuroprotective effects. A comprehensive 2023 narrative review in Pharmaceutics (PMID: 37111543) confirmed its health-promoting activities across stress reduction, cognitive enhancement, immune modulation, and hormonal balance, while a 2024 review in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (PMID: 38318860) evaluated its neuroprotective potential in neurodegenerative disease models.
Reported Benefits (Provisional)
Origin & History
Winter Cherry (Withania somnifera), commonly known as Ashwagandha, is an adaptogenic herb native to dry, subtropical regions of India, North Africa, and the Middle East. Its roots are highly prized in traditional medicine for their stress-modulating, cognitive-enhancing, and immune-strengthening properties.
Research Narrative (Provisional)
Mikulska et al. (2023) published a comprehensive narrative review in Pharmaceutics examining ashwagandha's health-promoting activities, including stress reduction, anti-inflammatory effects, cognitive enhancement, and immune modulation across multiple clinical trials (PMID: 37111543). The LiverTox/NLM monograph on Withania (2006, updated; PMID: 30000965) provides a detailed pharmacological and hepatotoxicity profile for Withania somnifera, documenting both efficacy data and rare cases of liver injury. Jhooty et al. (2024) reviewed Withania somnifera's neuroprotective potential in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, analyzing preclinical evidence for withanolide-mediated protection against motor neuron degeneration and oxidative stress (PMID: 38318860). Collectively, these studies support winter cherry's adaptogenic, neuroprotective, and immunomodulatory properties with varying levels of clinical evidence.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Phytochemicals/Bioactives: Withanolides (adaptogenic, anti-inflammatory, neuroprotective), Alkaloids (stress relief, immune support), Flavonoids, Saponins (cardiovascular, antioxidant support) - Amino Acids: Tryptophan (neurotransmitter balance, mood regulation) - Minerals: Iron (oxygen transport, energy production), Calcium, Magnesium (bone health, muscle function) - Macronutrients: Dietary Fiber (digestive health, gut microbiome balance)
Reported Mechanism (Provisional)
The primary bioactive compounds in winter cherry root—withanolides (particularly withaferin A, withanoside IV, withanoside VI, and withanolide D)—are steroidal lactones that downregulate cortisol secretion by modulating the hypothalamic-pituitary-adrenal (HPA) axis and inhibiting the enzyme 11β-hydroxysteroid dehydrogenase type 1. These withanolides enhance GABAergic signaling by acting as positive allosteric modulators at GABA-A receptors, producing anxiolytic and calming effects comparable to certain benzodiazepine-like mechanisms. Withaferin A crosses the blood-brain barrier and exerts neuroprotection through inhibition of NF-κB-mediated neuroinflammation, upregulation of superoxide dismutase (SOD) and catalase antioxidant pathways, and promotion of brain-derived neurotrophic factor (BDNF) expression to support neuroplasticity. Additionally, withanolides modulate the Nrf2/ARE antioxidant response element pathway and inhibit acetylcholinesterase activity, contributing to cognitive enhancement and cellular protection against oxidative damage.
Clinical Narrative (Provisional)
Multiple randomized controlled trials have demonstrated winter cherry's efficacy, with studies showing 23-27% reductions in morning cortisol levels in stressed adults taking 300-600mg daily. Clinical research includes stress reduction studies with 60-64 participants showing significant improvements in perceived stress scales and anxiety measures. Evidence is strongest for adaptogenic effects and moderate for cognitive enhancement, though larger long-term studies are needed to confirm cardiovascular and anti-aging benefits.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.